Cornerstone Therapeutics (Nasdaq: CRTX) Divests Its Anti-Infective Assets – Emailwire

Chicago, IL 3/7/12 (StreetBeat) — Cornerstone Therapeutics Inc. (NASDAQ: CRTX) today announced the divestiture of certain product rights to Factive® (gemifloxacin mesylate) tablets and the Spectracef® (cefditoren pivoxil) family of products in a series …